Dr Milind Desai on VALOR-HCM: Primary and Secondary Effects Are Sustained While on Mavacamten
September 16th 2023Secondary effects not only improved past 16 weeks, but showed a sustained improvement at week 56 of mavacamten, said Milind Desai, MD, MBA, director of the Hypertrophic Cardiomyopathy Center and vice chair of education at the Heart, Vascular & Thoracic Institute, Cleveland Clinic.
Watch
Dr Zachary Cox: Early Dapagliflozin Modestly Improves Diuresis, Decongestion for Patients With ADHF
September 14th 2023Despite not reaching statistical significance, findings from DICTATE-AHF show early dapagliflozin improved decongestion and led to earlier hospital discharge for patients with acute decompensated heart failure, explained Zachary Cox, PharmD, professor at Lipscomb University College of Pharmacy.
Watch
Dr Andre Harvin: Specialty Pharmacists Are Integral to Oncology Care
September 10th 2023Specialty pharmacy is a big area of growth, with opportunity for patients, and specialty pharmacists can help payers and insurers ensure that patients get the full value of oncology medications, noted Andre Harvin, PharmD, MS, MBA, chief pharmacy officer, Oncology Services, Cone Health Cancer Centers.
Watch
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen
Dr G. B. John Mancini on Payer System Differences Between the US and Canada
September 7th 2023Care quality is high in both the United States and Canada, but there are commonalities in regard to drug access and cost issues, particularly with advanced medications, noted G. B. John Mancini, MD, University of British Columbia.
Watch
Dr Milind Desai Highlights New Findings From VALOR-HCM Trial
September 5th 2023After 16 weeks on placebo, patients in the control group were invited to start mavacamten alongside the treatment group, explained Milind Desai, MD, MBA, director of the Hypertrophic Cardiomyopathy Center and vice chair of education at the Heart, Vascular & Thoracic Institute, Cleveland Clinic.
Watch
Dr Jordan Berlin Discusses Precision Medicine and Factoring Patient Preferences Into Treatment
September 5th 2023Jordan Berlin, MD, FASCO, of Vanderbilt University Medical Center, explained how patient preferences and new treatments are considered, as well as what he is currently working on and his biggest takeaway from The American Journal of Managed Care®’s Institute for Value-Based Medicine® held in Nashville, TN on August 17, 2023.
Watch
Laura Wingate: Biosimilars Can Improve Access to Treatment for Patients
September 3rd 2023Biosimilars can improve access to treatment for patients who might not have been able to access biologics previously, explained Laura Wingate, executive vice president, Education, Support, & Advocacy, Crohn's & Colitis Foundation.
Watch
Dr Sachin Jain on the Changing Doctor-Patient Relationship and Middlemen in Health Care
September 1st 2023Sachin Jain, MD, MBA, president and CEO at SCAN Group and SCAN Health Plan, discussed the growing roles of middlemen between physicians and their patients in an increasingly complex system.
Watch
Dr Jennifer Choe Discusses Head and Neck Cancer Relapse, New Treatment Trials, Promising Responses
September 1st 2023Jennifer Choe, MD, PhD, a head and neck medical oncologist at Vanderbilt University Medical Center, discussed head and neck cancer relapse post-radiation therapy, new treatment trials, and any promising responses from them.
Watch
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Dr Carmen Solórzano Explains VICC’s Tumor Boards, Implementing Patient Preferences
August 28th 2023Carmen Solórzano, MD, FACS, of Vanderbilt University Medical Center, discusses how Vanderbilt-Ingram Cancer Center (VICC) conducts tumor boards and explains how patient preferences are considered during them.
Watch
Dr Joseph Mikhael on Strategies to Increase Diversity in Multiple Myeloma Trials
August 28th 2023Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, highlights several potential strategies to address the historic lack of diversity in multiple myeloma clinical trial populations.
Watch